近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Garg, N., Yuki, N., Park, S., Barnett, M., Kiernan, M. (2016). Acute bulbar, neck and limb weakness with monospecific anti-GT1a antibody: A rare localized subtype of Guillain-Barre sydnrome. Muscle and Nerve, 53(1), 143-146. [More Information] Wang, C., Beadnall, H., Hatton, S., Bader, G., Tomic, D., Silva, D., Barnett, M. (2016). Automated brain volumetrics in multiple sclerosis: a step closer to clinical application. Journal of Neurology, Neurosurgery, and Psychiatry, 87(7), 754-757. [More Information] Barnett, M., Mathey, E., Kiernan, M., Pollard, J. (2016). Axon damage in central nervous system and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of dysfunction and tissue damage. Current Opinion In Neurology, 29(3), 213-221. [More Information] Zivadinov, R., Jakimovski, D., Gandhi, S., Ahmed, R., Dwyer, M., Horakova, D., Weinstock-Guttman, B., Benedict, R., Vaneckova, M., Barnett, M., et al (2016). Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine. Expert Review of Neurotherapeutics, 16(7), 777-793. [More Information] Klistorner, A., Wang, C., Fofanova, V., Barnett, M., Yiannikas, C., Parratt, J., You, Y., Graham, S. (2016). Diffusivity in multiple sclerosis lesions: At the cutting edge? NeuroImage: Clinical, 12, 219-226. [More Information] Barnett, M., McLeod, J., Hammond, S., Kurtzke, J. (2016). Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania. Journal of Neurology, 263(4), 792-798. [More Information] Barnett, M., McLeod, J., Hammond, S., Kurtzke, J. (2016). Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment. III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania. Journal of Neurology, 263(4), 792-798. [More Information] Klistorner, A., Wang, C., Yiannikas, C., Graham, S., Parratt, J., Barnett, M. (2016). Progressive injury in chronic multiple sclerosis lesions is gender-specific: A DTI study. PloS One, 11(2), 1-11. [More Information] Graham, E., You, Y., Yiannikas, C., Garrick, R., Parratt, J., Barnett, M., Klistorner, A. (2016). Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study. Investigative Ophthalmology & Visual Science, 57(4), 2311-2317. [More Information] Ramanathan, S., Prelog, K., Barnes, E., Tantsis, E., Reddel, S., Henderson, A., Vucic, S., Gorman, M., Benson, L., Alper, G., Barnett, M., Parratt, J., Hardy, T., Merheb, V., Nosadini, M., Fung, V., Brilot-Turville, F., Dale, R., et al (2016). Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Multiple Sclerosis Journal, 22(4), 470-482. [More Information] Spelman, T., Mekhael, L., Burke, T., Butzkueven, H., Hodgkinson, S., Havrdova, E., Horakova, D., Duquette, P., Izquierdo, G., Grand' Maison, F., Barnett, M., Vucic, S., et al (2016). Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis. European Journal of Neurology, 23(4), 729-776. [More Information] Warrender-Sparkes, M., Spelman, T., Izquierdo, G., Trojano, M., Lugaresi, A., Grand'Maison, F., Havrdova, E., Horakova, D., Boz, C., Barnett, M., et al (2016). The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis. Multiple Sclerosis Journal, 22(4), 520-532. [More Information] Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Parratt, J., Reddel, S., Spies, J., Pollard, J., et al (2015). A new era in the treatment of multiple sclerosis. Medical Journal of Australia, 203(3), 139-141. [More Information] Gu, B., Field, J., Dutertre, S., Ou, A., Kilpatrick, T., Lechner-Scott, J., Scott, R., Lea, R., Taylor, B., Stankovich, J., et al (2015). A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. Human Molecular Genetics, 24(19), 5644-5654. [More Information] Wang, C., Paling, D., Chen, L., Hatton, S., Lagopoulos, J., Aw, S., Kiernan, M., Barnett, M. (2015). Axonal conduction in multiple sclerosis: A combined magnetic resonance imaging and electrophysiological study of the medial longitudinal fasciculus. Multiple Sclerosis Journal, 21(7), 905-915. [More Information] Hardy, T., Beadnall, H., Sutton, I., Mohamed, A., Buckland, M., Barnett, M. (2015). Balo's concentric sclerosis and tumefactive demyelination: A shared immunopathogenesis? Journal of the Neurological Sciences, 348(1-2), 279-281. [More Information] Hardy, T., O’Brien, B., Gerbis, N., Barnett, M., Reddel, S., Brewer, J., Herkes, G., Silberstein, P., Garsia, R., Watson, J., Gupta, R., Parratt, J., et al (2015). Brain histopathology in three cases of Susac's syndrome: Implications for lesion pathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 86(5), 582-584. [More Information] Mathey, E., Park, S., Hughes, R., Pollard, J., Armati, P., Barnett, M., Taylor, B., Dyck, J., Kiernan, M., Lin, C. (2015). Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. Journal of Neurology, Neurosurgery and Psychiatry, 86(9), 973-985. [More Information] Kalincik, T., Jokubaitis, V., Izquierdo, G., Duquette, P., Girard, M., Grammond, P., Lugaresi, A., Oreja-Guevara, C., Bergamaschi, R., Hupperts, R., Barnett, M., et al (2015). Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 21(9), 1159-1171. [More Information] Spelman, T., Kalincik, T., Zhang, A., Pellegrini, F., Wiendl, H., Kappos, L., Tsvetkova, L., Belachew, S., Hyde, R., Barnett, M., et al (2015). Comparative efficacy of switching to natalizumab in active multiple sclerosis. Annals of Clinical and Translational Neurology, 2(4), 373-387. [More Information]